Stryker Corporation
SYK
Clasificación en acciones
#191
Stryker Corporation functions as a prominent medical technology enterprise,... Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
Precio por acción
$304.72
Capitalización bursátil
$116.88B
Cambio (1 día)
1.96%
Cambio (1 año)
-20.07%
País
US
Comercio Stryker Corporation (SYK)
Categoría
Healthcare
Ganancias de Stryker Corporation (SYK)
Ganancias en Jun 2026 TTM: $5.15B
Secondo gli ultimi rapporti finanziari di Stryker Corporation, gli utili attuali della società sono $5.15B. Nel 2024, la società ha registrato un utile di $3.49B, una disminución en comparación con agli utili del 2023, che erano di $3.67B. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Stryker Corporation desde 2000 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2026 (TTM) | $5.15B | 14.05% |
| 2025 | $4.51B | 29.27% |
| 2024 | $3.49B | -4.93% |
| 2023 | $3.67B | 36.90% |
| 2022 | $2.68B | 17.62% |
| 2021 | $2.28B | 16.73% |
| 2020 | $1.95B | -23.73% |
| 2019 | $2.56B | 8.74% |
| 2018 | $2.36B | 14.20% |
| 2017 | $2.06B | 7.39% |
| 2016 | $1.92B | 10.72% |
| 2015 | $1.74B | 49.57% |
| 2014 | $1.16B | -4.29% |
| 2013 | $1.21B | -28.91% |
| 2012 | $1.71B | 1.13% |
| 2011 | $1.69B | -2.52% |
| 2010 | $1.73B | 6.51% |
| 2009 | $1.62B | 2.77% |
| 2008 | $1.58B | 15.33% |
| 2007 | $1.37B | 24.13% |
| 2006 | $1.10B | 10.02% |
| 2005 | $1.00B | 39.93% |
| 2004 | $717.00M | 9.89% |
| 2003 | $652.50M | 28.77% |
| 2002 | $506.70M | 24.90% |
| 2001 | $405.70M | 21.14% |
| 2000 | $334.90M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| $7.51B | 45.90% |
US
|
|
| $5.56B | 8.06% |
IE
|
|
| $3.86B | -25.00% |
US
|
|
| - | - |
DE
|
|
| $1.42B | -72.46% |
US
|
